![](/img/cover-not-exists.png)
Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement
Salaun, P.-Y., Campion, L., Bournaud, C., Faivre-Chauvet, A., Vuillez, J.-P., Taieb, D., Ansquer, C., Rousseau, C., Borson-Chazot, F., Bardet, S., Oudoux, A., Cariou, B., Mirallie, E., Chang, C.-H., SVolume:
53
Language:
english
Journal:
Journal of Nuclear Medicine
DOI:
10.2967/jnumed.111.101865
Date:
August, 2012
File:
PDF, 914 KB
english, 2012